ORLANDO, Fla., May 9, 2018 /PRNewswire/ -- Nutriband Inc. (OTC: NTRB), a pharmaceutical and health company with a focus oninnovative transdermal solutions for prescription medications and consumer products, is pleased to announce that it has retained RedChip Companies to lead its investor relations efforts.
"As we move into our next phase of operations, it was
Nutriband's transdermal, or "through the skin," solutions cover a growing number of pharmaceutical applications offering several benefits, including consistent sustained delivery, enhanced convenience, increased tolerability, and the potential for fewer side effects. Transdermal prescription sales are growing at a rate of 11.6% year over year and is estimated to reach $125.8 billion by 2021. The Company's transdermal consumer product lines will provide innovative delivery alternatives for a variety of popular health supplements, a market estimated to reach $278 billion by 2024.
"We're pleased to be representing Nutriband," stated Dave Gentry, President & CEO of RedChip Companies. "Transdermal solutions represent a market opportunity in the hundreds of billions of dollars and Nutriband already has three Consumer products on the market. We look forward to introducing them to our institutional and retail investor networks."
About Nutriband Inc.
Nutriband is a unique, results-driven health and pharmaceutical company based in Orlando, Florida. Unlike traditional health product companies, Nutriband found its start by spotting and targeting a gross and virtually unexplored niche in the supplement market through its method of ingredient delivery. All Nutriband products are based around the science of transdermal / Topical technologies. www.nutriband.com – Corporate www.shopnutriband.com – Find a list of our products available for purchase
Certain statements contained in this press release, including, without limitation, statements containing the words "believes", "anticipates", "expects" and words of similar import, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. Our actual results may differ materially from those anticipated in our forward-looking statements as a result of a number of factors, including our ability to create, sustain, manage or forecast our growth; our ability to attract and retain key personnel; changes in our business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions. Except as required by applicable law, we undertake no obligation to revise or update any of our forward-looking statements in order to reflect any event or circumstance that may arise after the date hereof.
View original content:http://www.prnewswire.com/news-releases/nutriband-inc-retains-redchip-companies-to-lead-investor-relations-program-300645728.html
SOURCE Nutriband Inc.
Subscribe to our Free Newsletters!
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...
Are you gluten intolerant? Stay away from gluten allergy and celiac disease by shifting to ...
Moxetumomab pasudotox-tdfk is used to treat hairy cell leukemia (a form of chronic lymphocytic ...View All